Group | BMI | P-value | ||||
---|---|---|---|---|---|---|
1.0 + 1.0 | 0.5 + 1.0 | 0.5 + 0.5 | PV-Control | NV-Control | ||
1.0 + 1.0 | 64.9 ± 0.8 | 1 | 0.898 | 1.000 | 0.731 | 0.715 |
0.5 + 1.0 | 64.0 ± 0.9 | 0.898 | 1 | 0.975 | 0.568 | 0.534 |
0.5 + 0.5 | 64.6 ± 0.8 | 1.000 | 0.975 | 1 | 0.731 | 0.584 |
PV-Control | 66.8 ± 1.5 | 0.731 | 0.568 | 0.731 | 1 | 0.999 |
NV-Control | 66.8 ± 1.7 | 0.715 | 0.534 | 0.584 | 0.999 | 1 |
(a) | One week of age | Seven weeks of age | ||||
---|---|---|---|---|---|---|
High MAL | Low MAL | P-value | Positive | Negative | P-value | |
1.0 + 1.0 | 0 | 14 | − | 11 | 3 | 0.005 |
0.5 + 1.0 | 0 | 14 | − | 12 | 2 | 0.000 |
0.5 + 0.5 | 0 | 14 | − | 5 | 9 | 0.556 |
PV-Control | 0 | 12 | − | 1 | 11 | 0.008 |
NV-Control | 0 | 12 | − | 0 | 12 | 0.000 |
P-value | 1.000 | 0.000 |
||||
(b) | One week of age | Seven weeks of age | ||||
High MAL | Low MAL | P-value | Positive | Negative | P-value | |
1.0 + 1.0 | 9 | 5 | − | 14 | 0 | 0.015 |
0.5 + 1.0 | 4 | 10 | − | 14 | 0 | 0.015 |
0.5 + 0.5 | 6 | 8 | − | 13 | 1 | 0.159 |
PV-Control | 7 | 5 | − | 5 | 7 | 0.006 |
NV-Control | 6 | 6 | − | 4 | 8 | 0.000 |
P-value | 0.402 | 0.000 |
||||
(c) | One week of age | Seven weeks of age | ||||
High MAL | Low MAL | P-value | Positive | Negative | P-value | |
1.0 + 1.0 | 9 | 5 | − | 2 | 12 | − |
0.5 + 1.0 | 6 | 8 | − | 3 | 11 | − |
0.5 + 0.5 | 12 | 2 | − | 2 | 12 | − |
PV-Control | 5 | 7 | − | 0 | 12 | − |
NV-Control | 6 | 6 | − | 0 | 12 | − |
P-value | 0.104 | 0.275 |
Group | Dose at one week of age | Dose at four weeks of age | Sample size |
---|---|---|---|
1.0 + 1.0 | 1.0 mL | 1.0 mL | n = 14 |
0.5 + 1.0 | 0.5 mL | 1.0 mL | n = 14 |
0.5 + 0.5 | 0.5 mL | 0.5 mL | n = 14 |
PV-Control | Not vaccinated | 1.0 mL | n = 12 |
NV-Control | Not vaccinated | Not vaccinated | n = 12 |